Informations générales (source: ClinicalTrials.gov)
Evaluation of the Analgesic Effect of Ropivacaine in Topical Use at the Thin Skin Graft Donor Site
Interventional
Phase 3
University Hospital, Rouen (Voir sur ClinicalTrials)
décembre 2013
octobre 2018
02 février 2026
The aim of the study is to Evaluate of the analgesic effect of ropivacaine in topical use
at the thin skin graft donor site.
For Patient needing a thin skin graft < 320 cm2, randomization will be done in 2 groups,
one receiving the standard treatment (20 mL of physiologic serum) during the surgical
intervention in topical use to recover an alginate dressing (Algosteril)and the other
receive 20 mL of Naropein during the surgical intervention on alginate dressing.
The hypothesis of the study is the administration of ropivacaine will decrease the
post-operative pain compared to physiologic serum
Etablissements
| Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| UHRouen - 76031 - Rouen 2982652 - France | Contact (sur clinicalTrials) | ||||
Critères
Tous
- Patient older than 18 years old
- Patient needing a thin skin graft < 320 cm2 and which is possible on the thigh
- Patient who read the information letter and signed the informed consent
- Patient affiliated at a social security system
- Effective contraceptive method for more than 3 months for women of childbearing age
Exclusion Criteria:
- Contraindication to one of the medicine used (allergy, intolerance, potential drug
interaction)
- Treatment by classII or III of analgesics or analgesic dose of aspirin(>500mg per
day) at the inclusion or randomization time
- Preoperative EVA>0 at the skin graft donor site on the thigh
- Sensory disturbances of the lower limbs
- Cognitive disturbances not allowing investigations
- Pregnant or lactating women
- People deprived of discernment
- People deprived of their liberty by judicial or administrative authority
- Protected adult (guardianship or trusteeship)